Home LiteratureArticle Details

PMID: 84901 Published · ppublish English Case Reports Clinical Trial Journal Article Randomized Controlled Trial

Interferon therapy in myelomatosis.

Lancet (London, England) ·Vol. 1 ·No. 8110 ·1979-02-03 ·Pages 245-7

Mellstedt H, Ahre A, Björkholm M, Holm G, Johansson B, Strander H

Abstract

Four patients with myelomatosis (one IgG-chi-type, two IgA-chi, and one Bence Jones-x) were given human leucocyte interferon as the only treatment for from 3 to 19 months. Remission was complete in two patients and partial in the other two. Normal bone-marrow haematopoiesis was slightly inhibited. The disease has not so far progressed in any of the patients.

MeSH Terms

Aged Bence Jones Protein Blood Cell Count Female Follow-Up Studies Hematopoiesis Humans Immunoglobulin A Immunoglobulin Light Chains Interferons/therapeutic use Male Multiple Myeloma/diagnosis,drug therapy,immunology Remission, Spontaneous

Chemicals

Immunoglobulin A Immunoglobulin Light Chains Bence Jones Protein Interferons

Authors & Affiliations

6 authors, click to expand affiliations / ORCID

Mellstedt H

Ahre A

Björkholm M

Holm G

Johansson B

Strander H

Article Info

Journal

Lancet (London, England)

Abbr.

Lancet

ISSN

0140-6736

DOI

10.1016/s0140-6736(79)90770-0

Published

1979-02-03

Pages

245-7

Language

English

Region

England

NLM ID

2985213R

Subset

External Links

PubMed source DOI: 10.1016/s0140-6736(79)90770-0 View journal details

Analysis Services

Interferon therapy in myelomatosis.

Contact

WeChat Official Account